Phase 2 Trial to Evaluate Belzupacap Sarotalocan (AU-011) Via Suprachoroidal Administration in Subjects With Primary Indeterminate Lesions and Small Choroidal Melanoma
Aura Biosciences
Aura Biosciences
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Aura Biosciences
Medical University of Vienna
M.D. Anderson Cancer Center
Stanford University
Greater Houston Retina Research
National Institutes of Health Clinical Center (CC)